FOLFIRINOX versus Gemcitabine/nab-Paclitaxel as palliative first-line treatment of advanced pancreatic cancer: an Austrian observational Tri-Center comparative effectiveness analysis [Abstract]
Autor: | Riedl, J., Posch, F., Horvath, L., Gantschnigg, A., Renneberg, F., Schwarzenbacher, E., Moik, F., Barth, D., Schaberl-Moser, R., Stotz, M., Pichler, Martin, Stöger, H., Greil, R., Djanani, A., Schlick, K., Gerger, A. |
---|---|
Jazyk: | angličtina |
Rok vydání: | 2023 |
Databáze: | OpenAIRE |
Externí odkaz: |